Results 231 to 240 of about 57,983 (265)
Some of the next articles are maybe not open access.
American Journal of Critical Care, 1997
Malignant hyperthermia is a pharmacogenetic disease of skeletal muscle characterized by hypermetabolism that occurs on exposure to a triggering agent or agents. The most common agents are halogenated inhalational anesthetics and succinylcholine, a depolarizing muscle relaxant.
A D, Miranda +3 more
openaire +4 more sources
Malignant hyperthermia is a pharmacogenetic disease of skeletal muscle characterized by hypermetabolism that occurs on exposure to a triggering agent or agents. The most common agents are halogenated inhalational anesthetics and succinylcholine, a depolarizing muscle relaxant.
A D, Miranda +3 more
openaire +4 more sources
Acta Pathologica Japonica, 1982
A report is made of a 65‐year‐old male who died of a malignant hyperthermia of 42°C. Symptoms included muscle rigidity at the termination of operation for neck‐clipping of an aneurysm of the anterior communicating artery. Latent myopathy was observed in skeletal muscle, and a bleeding focus was present in the left anterior region of the hypothalamus ...
M, Ohmori +3 more
openaire +2 more sources
A report is made of a 65‐year‐old male who died of a malignant hyperthermia of 42°C. Symptoms included muscle rigidity at the termination of operation for neck‐clipping of an aneurysm of the anterior communicating artery. Latent myopathy was observed in skeletal muscle, and a bleeding focus was present in the left anterior region of the hypothalamus ...
M, Ohmori +3 more
openaire +2 more sources
The Journal of Pediatrics, 1986
The increasing use of intravenous and inhalation sedation in the dental office has the potential of increasing the incidence of malignant hyperthermia (MH) in susceptible subjects. The object of this article is to present two cases of MH and to discuss its pathophysiology, its clinical picture, and its management in the light of the current literature.
R Y, Cantin, A, Poole, J F, Ryan
+8 more sources
The increasing use of intravenous and inhalation sedation in the dental office has the potential of increasing the incidence of malignant hyperthermia (MH) in susceptible subjects. The object of this article is to present two cases of MH and to discuss its pathophysiology, its clinical picture, and its management in the light of the current literature.
R Y, Cantin, A, Poole, J F, Ryan
+8 more sources
Annals of Emergency Medicine, 1987
Malignant hyperthermia is a hereditary trait characterized by hypercatabolic reactions induced by anesthetic drugs, or physical or emotional stress. Patients must be treated quickly and efficiently in order to prevent irreversible organ damage and death.
J L, Tomarken, B A, Britt
openaire +2 more sources
Malignant hyperthermia is a hereditary trait characterized by hypercatabolic reactions induced by anesthetic drugs, or physical or emotional stress. Patients must be treated quickly and efficiently in order to prevent irreversible organ damage and death.
J L, Tomarken, B A, Britt
openaire +2 more sources
Critical Care Nursing Clinics of North America, 1991
Although MH is a rare disease, occurring 1 in 7000 to 14,000 anesthetics in children and one in 50,000 to 200,000 anesthetics in adults, the critical care nurses must possess knowledge of its causes and treatment. MH can be potentially fatal. With aggressive intervention, both morbidity and mortality will be reduced.
D D, Sinkovich, A E, Mitch-Resignalo
+7 more sources
Although MH is a rare disease, occurring 1 in 7000 to 14,000 anesthetics in children and one in 50,000 to 200,000 anesthetics in adults, the critical care nurses must possess knowledge of its causes and treatment. MH can be potentially fatal. With aggressive intervention, both morbidity and mortality will be reduced.
D D, Sinkovich, A E, Mitch-Resignalo
+7 more sources
The Journal of the American Dental Association, 1979
A case has been presented that illustrates successful managment of a patient with suspected malignant hyperthermia. The causes of this disorder are uncertain. If screening procedures identify a patient as susceptible to this disorder, careful planning in the preoperative stage is indicated.
openaire +4 more sources
A case has been presented that illustrates successful managment of a patient with suspected malignant hyperthermia. The causes of this disorder are uncertain. If screening procedures identify a patient as susceptible to this disorder, careful planning in the preoperative stage is indicated.
openaire +4 more sources
The American Journal of Surgery, 1977
Malignant hyperthermia of anesthesia is a severe complication and must be treated vigorously. The anesthetic should be stopped and the core body temperature reduced. Systemic complications must be anticipated, hopefully prevented, and appropriately treated. Appropriate laboratory studies must be obtained.
openaire +2 more sources
Malignant hyperthermia of anesthesia is a severe complication and must be treated vigorously. The anesthetic should be stopped and the core body temperature reduced. Systemic complications must be anticipated, hopefully prevented, and appropriately treated. Appropriate laboratory studies must be obtained.
openaire +2 more sources
2018
Malignant hyperthermia (MH) is a form of heat illness caused by increased heat generation exceeding the body's capacity for heat loss. It is classified separately from other forms of heat illness as the latter require assessment of mental function for differential diagnosis.
Philip M, Hopkins +2 more
openaire +2 more sources
Malignant hyperthermia (MH) is a form of heat illness caused by increased heat generation exceeding the body's capacity for heat loss. It is classified separately from other forms of heat illness as the latter require assessment of mental function for differential diagnosis.
Philip M, Hopkins +2 more
openaire +2 more sources
British Journal of Perioperative Nursing (United Kingdom), 2005
Malignant Hyperthermia (MH) is a rare genetic condition which may manifest for the first time during anaesthesia associated with a routine surgical procedure. Characterised initially by muscle rigidity, increased body temperature and metabolic acidosis, the syndrome may prove fatal unless prompt, effective treatment is administered.
openaire +2 more sources
Malignant Hyperthermia (MH) is a rare genetic condition which may manifest for the first time during anaesthesia associated with a routine surgical procedure. Characterised initially by muscle rigidity, increased body temperature and metabolic acidosis, the syndrome may prove fatal unless prompt, effective treatment is administered.
openaire +2 more sources